Zhou M - Search Results

1

A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022).

Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, Hora M, Kojima F, Kristiansen G, Kuroda N, López JI, Maclean F, Magi-Galluzzi C, Martignoni G, McKenney JK, Michalová K, Michal M, Mohanty SK, Netto GJ, Ohashi R, Ondič O, Osunkoya AO, Gomez MDPM, Petersson F, Picken MM, Pivovarcikova K, Rogala J, Shah RB, Siadat F, Skenderi F, Sperga M, Suster SM, Svajdler M, Tretiakova M, Trpkov K, Ulamec M, Williamson SR, Yang XJ, Zhou M, Vranic S, Vujanic G, Michal M. Alaghehbandan R, et al. Among authors: zhou m. Mod Pathol. 2022 Dec;35(12):2023-2024. doi: 10.1038/s41379-022-01159-8. Mod Pathol. 2022. PMID: 36333474 Free article. No abstract available.

2

[No title available]

[No authors listed] [No authors listed] PMID: 36344189

3

Should grade group 1 prostate cancer be reclassified as "non-cancer"? A pathology community perspective.

Zhou M, Amin A, Fine SW, Rao P, Siadat F, Shah RB. Zhou M, et al. Urol Oncol. 2023 Feb;41(2):62-64. doi: 10.1016/j.urolonc.2022.09.028. Epub 2022 Nov 23. Urol Oncol. 2023. PMID: 36428166

4

Hereditary succinate dehydrogenase-deficient renal cell carcinoma.

Rogala J, Zhou M. Rogala J, et al. Among authors: zhou m. Semin Diagn Pathol. 2024 Jan;41(1):32-41. doi: 10.1053/j.semdp.2023.11.001. Epub 2023 Nov 8. Semin Diagn Pathol. 2024. PMID: 37981479 Review.

5

Analytic Sensitivity of 3 Nucleic Acid Detection Assays in Diagnosis of SARS-CoV-2 Infection.

Sieker JT, Horowitz C, Hu CK, Lacombe-Daphnis M, Chirokas B, Pina C, Heger NE, Rabson AR, Zhou M, Bogen SA, Horowitz GL. Sieker JT, et al. Among authors: zhou m. J Appl Lab Med. 2021 Mar 1;6(2):421-428. doi: 10.1093/jalm/jfaa187. J Appl Lab Med. 2021. PMID: 33674879 Free PMC article.

6

Renaming Grade Group 1 Prostate "Cancer" From a Pathology Perspective: A Call for Multidisciplinary Discussion.

Paner GP, Zhou M, Simko JP, Eggener SE, van der Kwast T. Paner GP, et al. Among authors: zhou m. Adv Anat Pathol. 2023 Apr 17. doi: 10.1097/PAP.0000000000000400. Online ahead of print. Adv Anat Pathol. 2023. PMID: 37072903

7

Editorial Comment.

Zhou M. Zhou M. J Urol. 2024 Mar;211(3):390-391. doi: 10.1097/JU.0000000000003811.01. Epub 2023 Dec 15. J Urol. 2024. PMID: 38100832 No abstract available.

8

Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective.

Zhou M, Paner GP. Zhou M, et al. J Urol. 2023 Jul;210(1):23-25. doi: 10.1097/JU.0000000000003511. Epub 2023 May 1. J Urol. 2023. PMID: 37126310 No abstract available.

9

Urothelial Carcinoma: Update on Staging and Reporting, and Pathologic Changes Following Neoadjuvant Chemotherapies.

Aron M, Zhou M. Aron M, et al. Among authors: zhou m. Surg Pathol Clin. 2022 Dec;15(4):661-679. doi: 10.1016/j.path.2022.08.003. Epub 2022 Oct 13. Surg Pathol Clin. 2022. PMID: 36344182 Review.

10

"Papillary Adenoma-like" Renal Tumor with TFE3 Gene Rearrangement, A Potential Precursor to or Early Event in the Development of TFE3 Translocation Renal Cell Carcinoma.

Algarrahi K, Omoscharka E, Zhou M. Algarrahi K, et al. Among authors: zhou m. Int J Surg Pathol. 2023 Aug;31(5):592-595. doi: 10.1177/10668969221108747. Epub 2022 Jul 18. Int J Surg Pathol. 2023. PMID: 35850545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,754 results

Search Page

Filters